FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients
PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an …
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients Read More